GoNitro Espero announced the launch of GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. Espero announced the ...
GoNitro Espero announced that the Food and Drug Administration (FDA) has approved GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ...
The FDA has given its okay to Espero Pharmaceutical’s Gonitro that is indicated to provide or prevent acute relief to patients who suffer an attack of angina pectoris. The nitroglycerin sublingual ...
CHEST discomfort associated with paroxysmal nocturnal dyspnea is frequently quite distressing, and some patients describe this discomfort as pain. 1 During the past several years, we have noted in the ...
THE value of sublingual administration of nitroglycerin for relief of attacks of angina pectoris is well established. Nitroglycerin has also been advocated as a prophylactic — before exercise and so ...
Accordingly to New York Times journalist Natasha Singer, approximately four million prescriptions for nitroglycerin were written in the US in 2009 [1]. The American HeartAssociation statistics show ...
The FDA issued warning letters yesterday to two companies, Glenmark Generics of Mahwah, N.J. and Konec Inc. of Tucson, Ariz., warning them to cease distribution of unapproved sublingual nitroglycerin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback